DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Halcinonide

Halcinonide

  • (CD-P-PH/PHO) Report Classification/Justifica

    (CD-P-PH/PHO) Report Classification/Justifica

  • Steroids Topical

    Steroids Topical

  • Formulary Updates Effective January 1, 2021

    Formulary Updates Effective January 1, 2021

  • United States Patent (19) 20

    United States Patent (19) 20

  • HALOG® SOLUTION (Halcinonide Topical Solution, USP) 0.1 %

    HALOG® SOLUTION (Halcinonide Topical Solution, USP) 0.1 %

  • Prior Authorization PDL Implementation Schedule

    Prior Authorization PDL Implementation Schedule

  • Wo 2008/127291 A2

    Wo 2008/127291 A2

  • List of Formulary Drug Removals

    List of Formulary Drug Removals

  • Bryhali (Halobetasol Propionate)

    Bryhali (Halobetasol Propionate)

  • Hydrocortisone-17-Butyrate

    Hydrocortisone-17-Butyrate

  • Preferred Drug List Drug Class Review Announcement

    Preferred Drug List Drug Class Review Announcement

  • (12) Patent Application Publication (10) Pub. No.: US 2014/0234227 A1 Yelin Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2014/0234227 A1 Yelin Et Al

  • Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Psoriasis

    Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Psoriasis

  • Clobetasol Propionate Cream Versus Halcinonide Cream in Psoriasis

    Clobetasol Propionate Cream Versus Halcinonide Cream in Psoriasis

  • Topical Corticosteroids (Cont.) Neuraminidase Inhibitors

    Topical Corticosteroids (Cont.) Neuraminidase Inhibitors

  • Clobetasol and Halcinonide Act As Smoothened Agonists to Promote Myelin Gene Expression and Rxrγ Receptor Activation

    Clobetasol and Halcinonide Act As Smoothened Agonists to Promote Myelin Gene Expression and Rxrγ Receptor Activation

  • Cphi China-Apis, Intermediates & Fine Chemicals.Xlsx

    Cphi China-Apis, Intermediates & Fine Chemicals.Xlsx

  • EP USP EPISA ICRS BP Lot List 11122015 NL.Xlsx

    EP USP EPISA ICRS BP Lot List 11122015 NL.Xlsx

Top View
  • Topical Corticosteroids
  • Topical Hydrocortisone 17-Butyrate 21-Propionate In
  • Halog) Reference Number: HIM.PA.20 Effective Date: 08.28.18 Last Review Date: 11.20 Line of Business: HIM Revision Log
  • Prescription Drug List Changes
  • 03. Steroid Ladder
  • Corticosteroids Topical
  • NYS Medicaid Fee-For-Service Preferred Drug List PREFERRED DRUG LIST – TABLE of CONTENTS I
  • Previous Versions
  • Topical Steroid Potencies
  • Study Protocol
  • Search Strategies
  • List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
  • Customs Tariff - Schedule Xxi - 1
  • Stratum Corneum Absorption Kinetics of 2 Potent Topical Corticosteroid Formulations: a Pilot Study
  • Pharmacy Medical Necessity Guidelines: Topical Corticosteroids
  • DIPROLENE® Betamethasone Dipropionate Ointment, Organon Standard 0.05% W/W
  • Topical Formulations Comprising a Steroid
  • January 1, 2018


© 2024 Docslib.org    Feedback